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ABSTRACT 
There are many infectious diseases that may be biofilm mediated, medical device-mediated or from some other agent, are now becoming life-
threatening. Despite of availability of many antimicrobial agents, new drugs or therapeutics, these infections have continued to be a global health 
challenge. Nowadays, conventional antimicrobial agents have failed against many infections due to the emergence of multiple drug-resistant strains. 
Even, if there is a therapeutic efficacy of these drugs, there inappropriate amounts are resulting in an adequate therapeutic index, local and 
systematic side effects, including irritation, reduction in gut flora and other manifestations. To overcome such situations, nanostructures have 
exclusive physicochemical properties as they are ultra small, their size can be controlled, greater surface area to mass ratio, high reactivity and 
functionalizable structure. Encapsulation of antimicrobial drugs in these nanoparticle systems helps in reducing many side effects. It also helps in 
the sustained release of drug for a larger time period. Several metal and metal oxide nanoparticles such as silver, gold, zinc, etc. have shown a 
promising antimicrobial activity. Liposomes, polymeric nanoparticles, dendrimers, and solid lipid nanoparticles have achieved great success as 
efficient antimicrobial drug delivery systems. These nanoparticles use multiple biological pathways to exert their antimicrobial mechanism such as 
cell wall disruption, inhibition of RNA synthesis, protein synthesis, etc. Moreover,these preparations of nanoparticles are more cost-effective than 
that of antibiotic synthesis with lesser or no side effects. 
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The present review is focused on various classes of nanoparticles, 
along with their mechanism of action and various nanostructured 
delivery systems. For the same literature on nanotechnology and 
nanoparticles of last twenty years were studied. The various 
literature is studied for, how bacteria start developing resistance 
against traditionally used antibiotics and what are the various 
nanoparticles used as treating bacterial infection, to write this 
review. The present study also includes various drug delivery 
systems are used to deliver the drugs and flashed the light on the 
usage of nanoparticles as a potent antimicrobial agent. History of 
existence of microorganism dates back to more than 3.8 billion 
years. For ages, they have survived with greatest genetic and 
metabolic diversity. Some of them are causing many infectious 
diseases, whereas others are contributing in maintaining 
environmental factors. These bacteria usually live in microbial 
communities that are composed of various species. Microorganisms 
invade the epithelial surface and spread throughout the body via the 
circulatory system. The cells of the immune system like 
macrophages, phagocytes these invading microorganisms resulting 
in formation of phagolysosomes. Thereafter, by utilizing oxygen 
dependent or oxygen independent bacterial killing pathways these 
microorganisms are killed. But, some of them evade the macrophage 
digestion and thereby resulting in intracellular infection and thus in 
diseases [1]. For such microorganisms antimicrobial drugs are the 
answer that kills or inhibit the growth of invading microorganism. 
Use of antimicrobial drugs dates back to 1928, when Alexander 
Fleming began the antimicrobial drug era with Penicillium [2]. 
Afterward, many other antimicrobial drugs like chloramphenicol, 
streptomycin and many others came into light. Antimicrobial kills 
the microorganism by binding with the some of the important 
components required for their metabolism and hence inhibiting 
their synthesis of functional biomolecules. Like, penicillin and 
cephalosporins inhibit the bacterial cell wall synthesis whereby the 
tetracycline inhibits protein synthesis. 
But with the advent of biofilm, conditions have become worse. 
Biofilm-associated infectious diseases have been estimated as one of 
the major causes of many microbial infections in the body, resulting 
in morbidity and mortality. Biofilms are actually the agglomerates of 
microorganisms that affix themselves to the surfaces by secreting 
various binding molecules like adhesion proteins. After settling 
down on the surface, they start proliferating and forms colonies 
inside the peptidiglycan envelop, ultimately resulting in the 
formation of mature biofilm. At this mature stage, it becomes 
difficult for even the body’s immune system to recognize them, as a 
result, it changes to chronic infection. Available antibiotics are not 
sufficient to fight back with these biofilms. Moreover, many 
microorganisms have become resistant to available antibiotics [3].  
The concept of evolution by natural selection is one of the major 
grounds behind this. As all the living organisms are continually 
adjusting to cope better with the environment. Microbes are no 
exception to this phenomenon. They are defending themselves 
against these antimicrobials by diverse mechanisms. They may alter 
the drug target, inactivate the enzyme, inhibit efflux transport or 
develop alternate metabolic pathways for their growth. There are 
more than 70% infections causing bacteria that have developed 
resistance for one of the commonly used drug for their treatment. 
Now, it has been established fact that continuous usage of these 
antimicrobials is the most important factor that has brought 
evolutionary changes in these microorganisms, that appears in the 
form of resistance against microorganism [4]. In addition to this 
there are certain other factors which include;  
a) Hospitalization for a longer period of time 
b) Usage of suboptimal dosage of particular antibiotics 
c) Increased rate of usage of enveloping devices and catheters 
d) Usage of antibiotics in other fields like that of agriculture and 
household. 
Mechanism of antimicrobial agents 
For the better understanding of resistance against antimicrobial 
agents and to find out the solution of this resistance, it’s necessary to 
understand the action of antimicrobial agents. Broadly antimicrobial 
agents are either bacteriostatic or bactericidal [5]. Bacteriostatic 
agents inhibits or stops the further proliferation and growth of 
invading microorganism and also takes a help of the host immune 
system for the killing of invading microorganism. While bactericidal 
agents with or without the support of the host immune system kills 
the invaded microorganism [6]. These antimicrobial agents actually 
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affect the metabolism of invading microorganism by the any of the 
following methods 
a) They inhibit nucleic acid synthesis 
b) They inhibit cell membrane function 
c) They inhibit cell wall synthesis 
d) They inhibit ribose synthesis 
Various antibiotics follow various paths for their antimicrobial 
activity. The mechanism of penicillin is bactericidal in which they 
inhibit the cell wall synthesis, tetracyclines are bacteriostatic in 
nature and inhibits the protein synthesis, carbapenems are 
bactericidal in nature and inhibits the cell wall synthesis; quinolones 
are bactericidal and inhibits DNA synthesis; sulfonamides and 
macrolides are bacteriostatic and follows competitive inhibition and 
inhibition of protein synthesis [7]. 
Resistance against antimicrobial agents 
Before 1990’s no case of antibiotic resistance was observed much, 
but gradually their number started increasing. Microorganism was 
becoming resistant to ensure their survival and they achieved it by 
developing many mechanisms based on the chemical structure of 
antimicrobial agents. Their mechanism includes:  
a) Reduction in uptake of antimicrobial agent 
b) New system for efflux of antimicrobial agent 
c) Overexpression of the target for the antimicrobial agent 
d) Secretion of alternative enzyme rather than the enzyme for 
which antimicrobial drug was targeted 
e) Through mutation changes in the binding site of the 
antimicrobial agent which reduces the binding of antimicrobial 
agent with that of the microorganism. 
There are various categories of these antibiotics and microorganism 
develops various mechanisms for different antibiotics. 
Resistance for β-lactum antibiotics 
β-lactum antibiotics includes penicillins, cephalosporins, 
carbapenems and cephamycin. In these antibiotics, β-lactum ring 
plays an important role which inactivates the set of transpeptidases 
required for peptidoglycan synthesis in bacteria [8]. With the 
passage of time microorganism developed resistance and develop 
mechanism either by an alteration in drug target enzyme or 
alteration in permeability, so that drug cannot reach the target [9]. 
Glycopeptide resistance 
These comprise of vancomycin and teicoplanin. Their antimicrobial 
activity is due to binding of D-alanyl-D-alanine side chain of 
peptidoglycan and thus inhibits the synthesis. Now, Microorganisms 
has developed a mechanism through which they started secreting D-
ala-D-ala ligase resulting in the rebuilding of peptidoglycan side 
chain to express D-alanyl-D-lactate type that has less affinity 
towards the glycopeptide drugs [10]. 
Tetracycline resistance 
Tetracycline is another important class of antibiotics that are 
commonly used against a wide range of Gram negative and Gram 
positive bacteria, and another class included is mycoplasmas, 
chlamydiae, rickettsiae, and protozoan parasites. There common use 
is for both of humans and in veterinary are attributed to their easy 
availability, low cost, low toxicity and effectiveness against wide 
spectrum. These were discovered in 1940’s, to exert their effect 
against microorganism, they prevent the attachment of aminoacyl-
tRNA to the ribosomal acceptor (A) site and thereby inhibiting the 
protein synthesis. Most commonly used drugs of this class include 
tetracycline, doxycycline, minocycline [11]. For this particular 
antibiotic, they utilize the export protein, which is from the major 
facilitator superfamily. These proteins are membrane-associated 
and are coded by tet efflux genes. These genes transport the 
tetracycline from the cell. As a result, there is a reduction in the 
intracellular drug concentration due to which the ribosomes are 
protected within the cell. Theses tetracycline efflux proteins have 
similar protein and amino acid structure like that of other efflux proteins 
that are involved in multi-drug resistance quaternary ammonium 
resistance, and chloramphenicol and quinolone resistance [12]. 
Chloramphenicol resistance 
Chloramphenicol is an antibiotic that also attacks on the ribosomal 
unit of microorganism. It binds itself to the 50s ribosomal unit and 
inhibits the peptidyl transferase of protein synthesis. Microorganism 
develops resistance against this antibiotic by developing such a 
mechanism that inhibits the binding of antibiotic with its ribosomal 
unit. It inhibits the activity of antibiotic by the release of enzyme 
chloramphenicol acetyltransferase. In Gram negative bacteria and in 
gram a positive bacterium this enzyme is released with the support of 
cat gene. Sometimes the resistance is developed due to the active drug 
efflux system or may be decreased outer membrane permeability [13]. 
Aminoglycoside resistance 
Aminoglycosides are a class of antibiotics that are distinguished by 
the presence of an aminocyclitol ring which is linked to the amino 
sugars in their structure. They have potency against a broad range of 
bacteria. This class includes streptomycin, kanamycin, gentamycin, 
tobramycin, and amikacin that are commonly used against the 
infection caused by many gram positive and gram negative bacteria. 
The antimicrobial potential of this drug is due to the irreversible 
binding of the drug with the ribosome, this blocks the protein 
synthesis in the bacteria. To resist against this antibiotic bacteria has 
developed such a mechanism that they modify aminoglycoside by 
generating more than 50 aminoglycoside-modifying enzymes [14]. 
There are many modifying enzymes and depending upon their type 
of modification they are classified as: aminoglycoside 
nucleotidyltransferases, aminoglycoside phosphotransferases and 
aminoglycoside acetyltransferases. The aminoglycoside 
acetyltransferases induce modification of aminoglycoside at the 
amino group, while aminoglycoside phosphotransferases and 
aminoglycoside nucleotidyltransferases induces modification at a 
hydroxyl group of aminoglycoside [15]. Due to these modifications 
aminoglycoside losses, its ability to bind with the ribosome and 
hence could not modify the protein synthesis of bacteria. In addition 
to this, bacteria follows efflux mechanism and rRNA mutations [16]. 
Quinolone resistance 
Quinolone is another class of antibiotics that was discovered in 1962 
during the synthesis of chloroquine and antimalarial drug. During 
that time its nalidixic salt was discovered. Thereafter its many 
derivatives were introduced in the market against many bacterial 
cells. Of all the salts discovered fluoroquinolones are the most 
important one with the subsititution of fluorine atom at 6 position of 
quinolone molecule. By the substitution of fluorine atom at 6 
position the potential of quinolone was enhanced to a greater extent. 
These agents exert their effect by inhibition of certain important 
enzymes that are required in DNA synthesis. These agents attack 
bacterial topoisomerase enzymes viz., DNA topoisomerase IV and 
DNA topoisomerase II (DNA gyrase). After being altered by the drug 
theses enzymes alter the topology of double-stranded DNA, thereby 
inhibiting its synthesis. To overcome this drug attack bacterial 
generation has developed resistance against this drug by one of the 
mechanism: they either develop a mechanism for alteration in drug 
target enzyme or they alter the permeability mechanism for the drug 
[17]. In Gram negative bacteria topoisomerase-II is the target 
enzyme for the drug (quinolones) while in gram positive bacteria it 
is topoisomerase-IV. Whatever were the targets, but the bacteria 
followed changes in the amino acid sequence by substitution within 
the quinolone resistance-determining region where, they replaced 
the hydroxyl group with bulky hydrophobic residue. This 
conformational change has brought a change in the binding site of 
the drug. As a result, drug was unable to bind with the specific 
enzymes and thus was not able to kill the bacteria [18]. 
Macrolide, lincosamide, and streptogramin (MLS) 
Macrolide, lincosamide, and streptogramin are special classes that 
inhibit the bacterial protein synthesis. In gram, negative bacteria 
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mechanism for resistance against this class includes low 
permeability of the cell membrane towards these hydrophobic 
compounds. But the Gram positive bacteria have developed various 
mechanisms that are as follows:  
• By utilizing adenine-N6-methyltransferase they induce a post-
transcriptional modification in 23 S rRNA that alters a binding site of 
MSLB antibiotics. 
• An activated drug efflux mechanism that pumps out the drug, and 
thus there is low concentration inside the cell which saves the 
ribosome.  
• Release of hydrolytic enzymes that modify the antibiotic by the 
addition of acetyl group. 
Sulfonamides and trimethoprim resistance 
Sulfonamides are bacteriostatic and to inhibit the bacterial growth 
they follow the competitive inhibition pathway. Gram negative 
bacteria have developed resistance for sulfonamides by the 
attainment of either of the two gene sul1 and sul2 that secrets 
dihydropteroate synthase enzyme, which is not repressed by the 
drug [19]. Trimethoprim also follows the pathway of competitive 
inhibition. Enzyme dihydrofolate reductase is required in the 
bacterial metabolism for the synthesis of amino acid and 
nucleotides. Trimethoprim is an analogue to dihydrofolic acid and 
with the help of dihydrofolate reductase, it helps in the synthesis of 
amino acid and nucleotides. This drug actually binds with the 
enzyme in a competitive manner and inhibits the normal 
metabolism of the bacterial cell. To sustain bacterial population now 
evolved a mechanism that deactivates this drug by any one of the 
mechanism; they started overproduction of the dihydrofolate 
reductase enzyme; adopted mutation in the dihydrofolate reductase 
enzyme gene for the attainment of another gene (dfr) that encodes 
resistant dihydrofolate reductase enzyme gene. So far 15 
dihydrofolate reductase enzyme type has been recognized [20]. 
Multidrug resistance 
With the passage of time and in the urge to survive these organisms 
has developed multidrug resistance, which has become a gigantic 
challenge in infectious disease management. It is believed that this 
multidrug resistance is mediated by the genetic mobile element like 
integrons, transposons and plasmids [21]. These organisms most 
commonly are resistant to chloramphenicol, penicillin, 
erythromycin, tetracycline, trimethoprim and tetracycline. 
One of the most resistant mutants is NDM-1, first came in to view in 
New Delhi and now has spread worldwide. NDM-1 is a New Delhi 
metallo beta-lactammase enzyme produced by Klebsiella that 
confers bacterial multiple drug resistance. It was identified in a 
patient that is not responding to any antibiotic [23]. These microbes 
replicate so fast that if the very small number of them become 
resistant, the resistant strain replicates, increase their number and 
spread throughout the population. One of the major limitations in 
using higher doses of antimicrobials is that they cause toxicity like 
ototoxicity or nephrotoxicity to healthy tissues.  
These days due to lack of other alternatives most of the biofilm-
mediated infections are treated with antibiotics only. Although 
attaching mature biofilm with these antibiotics does not work and 
much higher dosage is required. Because these drugs cannot 
penetrate the extracellular polysaccharide sheath which covers the 
biofilm. Theses biofilm-associated bacteria’s are less susceptible to 
the antibiotics than that of the planktonic bacteria [24]. Moreover; it 
is not possible for the host to tolerate very high dosage of available 
antimicrobials [25]. 
Nanotechnology has brought some hopes to act as new alternative 
antimicrobial agent. Nanostructures have large surface area relative 
to their size and provide high activity, even at a very low dose. The 
mode of action of the nanoparticle is mainly by direct contact with 
bacterial cell wall and it does not need to penetrate the cells. This 
brings the hope that nanoparticles would be less prone to resistance 
like that of antibiotics. 
Nanoparticles over conventional drugs 
Over the last few decades, in the search of new antimicrobials 
application of nanotechnology has shown promising applications to 
overcome the problem of antibiotic resistance [26, 27]. 
Nanostructures are very small (nanoscale) in size, and the structure 
is formulated in such a way that there are a large number of atoms at 
the surface level relative to the total number of atoms. This factor 
actually imparts unique characteristics to the nanostructures, their 
surface to volume ratio becomes large and their electronic energy 
states become discrete, and this leads to exceptional electronic, 
optical, magnetic and mechanical properties. Antimicrobial 
nanostructures are usually made from the organic and inorganic 
materials and thus are classified as organic nanoparticles and 
inorganic nanoparticles. After bringing the organic and inorganic 
material to nanoscale their property changes to a greater extent, 
their easily operatable (as per the requirement) crystallographic 
surface structure and a large surface to volume ratio makes them 
attractive tool to solve the various problems. Due to their small size 
like that of other biological molecules and structures, they are 
extensively explored in the field of medicine. In medicine, they are 
mainly utilized in targeted drug delivery, imaging, sensing, artificial 
implants and as antimicrobials. The drug is entrapped, encapsulated, 
dissolved or attached to the matrix. Depending upon the preparation 
method nanospheres, nanoparticles or nanocapsules are formed.  
Physical encapsulation, adsorption or chemical conjugation is the 
techniques used for loading of drugs in the nanoparticles. By 
utilizing drug loaded Nanoparticles pharmacokinetics and 
therapeutic index of the drugs can be improved significantly. 
In nanocapsules, the drug is confined to the cavity surrounded by a 
unique polymer membrane. Nanosphere themselves is a matrix 
system in which drug is physically and uniformly dispersed. 
  
 
Fig. 1: Various types of drug delivery systems based upon the type of matrix used [22] 
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Inorganic and organic nanoparticles 
Inorganic nanoparticles 
There are many metals or metal oxides that have been widely studied 
for their antimicrobial potential. It includes silver, gold, titanium oxide, 
zinc oxide, etc., it is believed that most of the metal oxide nanoparticles 
exert an antimicrobial effect by following the mechanism of reactive 
oxygen species generation; some are effective by generations of their 
ions or sometimes due to their physical structure [28]. 
Silver nanoparticles 
Silver nanoparticles have been widely used for various micro-
organisms, due to the potency of silver particle being themselves as 
antimicrobial agents. Before the antibiotic era people used to take this 
metal to treat burns, open wounds and various infectious diseases. Its 
traditional use was clogged after the advent of antibiotics, but now 
again it has acquired the popularity to be used as silver nanoparticles. 
There are many mechanisms proposed for the efficacy of silver 
nanoparticles as an antimicrobial agent. It is implicated that silver has 
a high affinity for sulphur and phosphorous, due to which they exert 
adverse effects on bacteria. There is a sulphur containing proteins on 
the bacterial cell membrane, silver nanoparticles reacts with sulfur-
containing amino acids and thus affects the cell viability. 
Similarly, silver ions released from these nanoparticles get themselves 
attached to phosphorous moieties into DNA and inactivates DNA 
replication, resulting in the death of microbial population [28, 29]. It is 
also suggested that attachment of silver nanoparticles to sulfur-
containing proteins of cell membrane increases cell permeability, 
leading to the death of bacterial population [30]. The concentration of 
Ag+released from these nanoparticles shows various effects. At the 
lower concentration, these ions (Ag+) uncouple respiratory electron 
transport from oxidative phosphorylation, thus inhibiting respiratory 
chain enzymes or disturb the membrane permeability [31]. Whereas, 
at higher concentration, it interacts with cytoplasmic components and 
nucleic acid resulting in their damage and thus cell death [32]. It has 
also been postulated that their small size less than 10 nm makes pores 
in the cell wall, releasing the cytoplasmic content into the medium, 
which leads to cell death [34]. Later, to enhance the bioactivity 
composites of these silver nanoparticles with various polymers was 
introduced [33-35]. Of all other polymers, chitosan (cationic 
polysaccharide) gained the maximum success, it is composed of (1,4)-
linked 2-amino-2-deoxy-β-D-glucose units. The composite was made 
by directly attaching the silver particles to glucose units, and it has 
shown more enhanced antimicrobial efficacy than its individual 
components. Polycationic chitosan binds to the negatively charged cell 
membrane, which decreases the osmotic stability of cell membrane, 
simultaneous silver particles create pores in the membrane, causing 
rapid disintegration of cell wall [36]. It has been found that silver 
nanoparticles showed promising results against many resistant 
bacteria. Methicillin-resistant Staphylococcus aureus showed the 
maximum sensitivity for silver nanoparticles followed by Methicillin-
resistant Staphylococcus epidermidis and Streptococcus [37]. These 
particles were found to be effective against Salmonella typhi and 
Klebsiella pneumonia [38]. In addition to concentration, various 
shapes also affected the antimicrobial activity. As it has been found 
that triangular silver nanoparticles were more effective against E. coli 
than that of spherical or rod-shaped [39]. 
Gold nanoparticles 
The use of gold particles in rejuvenation has been very well 
documented in the Indian Ayrvedic system (Swarna Bhasam), in 
Chinese medical history and also in the western world (nervine). Its 
first bacteriostatic effect was studied by Robert Koch in 1920 against 
M. tuberculosis [40]. Gold nanoparticles are biologically inert but can 
be engineered to possess chemical or photothermal functionality. 
They can be made active on near infrared radiation. At this range, 
they can annihilate bacterial cells by photothermal heating. By 
utilizing photothermal radiation in combination with photo-
sensitizers they have been found to be effective against Methicillin-
resistant Staphylococcus aureus. Toluidine blue O which is a 
photosensitizer has been conjugated on the surface of Gold 
nanorods, working as both photodynamic and photothermal agent 
and utilized for photodynamic antimicrobial chemotherapy [41]. 
This combination actually inactivates Methicillin-resistant 
Staphylococcus aureus. Recently, these light-absorbing nanorods 
conjugated with specific antibodies and found to be effective against 
Staphylococcus aureus by using laser [42]. Theses gold nanoparticles 
later made conjugated with antibiotics like vancomycin, which killed 
vancomycin-resistant enterococci [43]. Likewise, cefaclor 
(antibiotic) in combination with gold nanoparticles have strong 
antimicrobial activity on both Gram-positive (S. aureus) and Gram-
negative bacteria (E. coli) compared to cefaclor and gold 
nanoparticles alone. Theses antibiotics actually inhibit the formation 
of peptidoglycan layer and simultaneously gold particles make the 
cell wall porous and generate holes in the cell wall which leads to 
leakage of cellular component and thus, cell death. Gold particles 
also found to get bind with DNA, inhibiting its transcription [44]. 
Zinc oxide nanoparticles 
Zinc oxide nanoparticles are found to be highly toxic to pathogenic 
strain while the minimal effect on human cells [45]. They have the 
ability to sustain the harsh conditions, which favours their 
application as a potent antimicrobial agent [46]. Furthermore, 
their potential to act as an antimicrobial agent depends upon 
concentration and particle size. They are also found to completely 
lyse the foodborne bacteria Salmonella typhimurium and 
Staphylococcus aureus [47].  
They work by disintegrating the cell membrane and increases 
membrane permeability resulting in leakage of cellular components 
and leads to death. They can be used against food-related bacteria 
Bacillus subtilis, Escherichia coli and Pseudomonas fluorescens, Listeria 
monocytogenes, Salmonella enteritidis [48]. Another mechanism that 
zinc nanoparticles follows is the generation of hydrogen peroxide from 
the surface of zinc oxide nanoparticles, which due to oxidative stress 
inhibits the bacterial growth [49]. Also, the release of Zn2+ions 
damages the cell membrane and interacts with the intracellular 
contents and thereby disturbing their functionality [46]. In addition to 
this, they have a white color, UV blocking ability and also prevent 
biofilm formation which makes them more suitable to be used as a 
coating material designed for the medical field [50]. 
Titanium dioxide nanoparticles 
These nanoparticles showed their activity due to the photocatalytic 
generation of strong oxidizing power when illuminated with UV 
light. Titanium dioxide nanoparticles are first illuminated with UV 
light, Photoexcitation TiO2 generates active hydroxyl radicals, which 
catalyze the bacterial killing [51, 52]. These nanoparticles are found 
to be effective on E. coli biofilm, against bacteria and fungi. These are 
also helpful in disinfecting contaminated surfaces and can be proven 
to be helpful for preventing biofilm formation. Their mechanism 
mainly based upon the generation of reactive oxygen species. 
Magnesium oxide nanoparticles 
Magnesium oxide nanoparticles are highly ionic with the greater 
surface area and crystal morphology, providing it numerous surface 
reactive sites. Aerogel magnesium oxide nanoparticles (prepared by 
aerogel procedure) are square and polyhedral in shape with a 
diameter of 4 nm. These have the unique property that they can 
adsorb a significant amount of chlorine and bromine and can retain 
them for a longer time period, as a result, can work as potent 
disinfectant [53]. These nanoparticles have greater surface area and 
enhanced surface reactivity, due to which they can adsorb higher 
amount of halogen. As their size is also very small so they can cover a 
larger number of bacteria and can bring halogen in greater proximity 
to the cells [54].  
These types of nanoparticles have shown excellent activity against E. 
coli¸ Bacillus megaterium and Bacillus subtilis. Halogenated 
magnesium oxide nanoparticles show positive charge in water 
suspension, which is opposite to that on the bacterial and spore 
cells. As a result, in water suspension due to opposite charges these 
two makes aggregates composed of AP-MgO nanoparticles and 
bacteria. Thereafter they affect the cell wall and leads to the death of 
the microorganism [55]. 
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Copper oxide nanoparticles 
Copper oxide is a semiconducting compound having superconductivity, 
spin dynamics and electron correlation effects. Its functionalities like 
photocatalytic or photovoltaic properties and photoconductive makes it 
more accessible for application as an antimicrobial agent [56]. Copper 
oxide nanoparticles are found to be more effective against bacterial 
pathogens involved in hospital-acquired infections [57]. Copper ion 
release from copper oxide nanoparticles has a great affinity towards the 
amines and carboxyl groups that are abundantly present on the surface 
of B. subtilis, due to which it has been found to be quite effective against 
B. subtilis Moreover, the copper ion released interacts with bacterial DNA 
and intercalate with the nucleic acid. These copper ions disrupt the 
biochemical process and thus help in the killing of bacteria [58]. 
Aluminium nanoparticles 
Aluminium oxide nanoparticles are found to be effective at higher 
concentrations. At a near neutral pH alumina nanoparticles possess 
a positive charge on its surface. Whereas, the surface of E. coli cells 
are negatively charged. Due to this, there is an electrostatic 
interaction between the negatively charged E. coli cells and 
nanoparticles, resulting in adhesion.  
As the concentration increases, adhesion also increases. But alumina 
nanoparticles are free radical scavengers, so here the bacterial 
killing is due to the structure of the particle rather than reactive 
oxygen species [59]. 
Nitric oxide 
The antibacterial potential of the Nitric oxide nanoparticle is 
dependent upon the size and shape. Being very reactive its clinical 
use is limited. Its mechanism to act on microorganism is through the 
release of reactive nitrogen species. It has shown promising result 
against methicillin-resistant S. aureus [61].  
In table 1 many metal and metal oxide has been briefly described. 
 
Table 1: Effective metal and metal oxides as nanoparticles 
Metal/Metal 
oxide 
Effective against Proposed mechanism Reference 
Silver Pseudomonas aeruginosa 
Ampicillin resistant E. coli 
Erythromycin-resistant 
Streptococcus pyogenes 
Shows bacteriostatic mechanism by 
-Inhibits cell wall synthesis 
-Inhibits Protein and Nucleic acid synthesis 
18 
Gold E. coli 
Staphylococcus aureus 
Inhibition of peptidoglycan layer and generation of pores in the cell wall resulting 
in leakage of intracellular material and thus cell death 
19 
Zinc oxide Enterotoxigenic E. coli 
Botrytis cinerea 
Penicillium expansum 
Causes deformation in fungal hyphae and thus inhibits the growth 20 
Prevent development of Conidiophores and conidia leading to the death of fungal 
hyphae 
 
Disruption of cell membrane, lipids and proteins, leading to leakage of the 
intracellular component and thus death 
 
Aluminium oxide E. coli At higher concentration disrupts cell wall 21 





These are polymeric nanoparticles having polycationic property and 
believe to kill microorganism by either of the mechanism, in some 
cases, they release antibiotics or another antimicrobial agent, or by 
contact killing through cationic surfaces which includes quaternary 
ammonium compounds, alkyl pyridiniums, or quaternary 
phosphonium. Largely it has been stated that theses cationic groups 
are able to disrupt the bacterial cell membrane, while some utilize 
hydrophobic chains of a certain length with which they penetrate 
inside the bacterial wall and burst the bacterial membrane. As they 
have sufficient amount of positive charge so by an ion exchange 
mechanism between the bacterial membrane and charged surface, 
they have shown the efficient potential against many micro-
organisms. To kill the bacteria they mainly follow the contact killing 
mechanism where theses polycationic entities possess multiple 
charges and get attached to the bacterial membrane [62]. Organic 
nanoparticles are less stable at a higher temperature, and cannot 
withstand the harsh conditions, due to which they are less 
preferable as compared to inorganic nanoparticles. 
Quaternary ammonium compounds  
Most commonly used quaternary ammonium chloride stearalkonium 
chloride, and cetrimonium chloride that acts as a disinfectant and their 
antimicrobial property is due to N-alkyl chain length. The interaction 
between positively charged moieties of the compound interacts 
electrostatically with the negatively charged bacterial membrane, 
thereby long hydrophobic tail of the compound integrates with 
hydrophobic membrane core where, they denature proteins and 
enzymes of the bacteria, resulting in the disruption of their mechanism 
and hence the death of the bacteria. Compound with a chain length of 
12-14 alkyl groups has shown moderate activity against gram negative 
bacterial, whereas alkyl groups with a chain length of the carbon 
chains showed good activity against gram negative bacteria [63]. 
Quaternary pyridiniums compound has a heterocyclic ring having a 
nitrogen atom, and they have pyridinium group in the polymer chain 
which is responsible for the antimicrobial activity. 
Polyethyleneimine is a synthetic nonbiodegradable, cationic 
polymer that has a primary, secondary, and tertiary amino functions. 
It has been made attached to many organic and inorganic, natural 
and synthetic, macroscopic and nanoscaled, monolithic and porous 
surface material. They have been found to be active against 
waterborne and airborne bacteria and fungi. These have been found 
to be effective against pathogenic and antibiotic-resistant strains 
without any report of the emergence of resistance. They basically 
rupture the cell membrane and results in the death of the 
microorganism. They are even friendly to mammalian cells. 
Imidazole derivatives have also been found to be a very effective 
antimicrobial polymer. They have the ability to form a hydrogen 
bond with drugs and proteins while its alkylated form known as 
imidazolium has the ability to aggregate electrostatically. They are 
quite stable and biocompatible to mammalian cells [64]. 
Organometallic polymers 
Organometallic polymers have metals either in the backbone or 
present in the pendant group. Organotin polyamine ethers are one 
such derived group that has cyclovir in their backbone. They have 
shown promising results against herpes simplex virus-1 and varicella-
zoster virus. They function by inhibiting RND and DNA of viruses [64]. 
Cationic quaternary polyelectrolytes  
Acrylic or methacrylic derivatives are most commonly known as 
cationic quaternary polyelectrolytes. Their main mechanism for 
antimicrobial activity involves the membrane disruption of bacteria. 
These compounds provide wide flexibility by the alteration of 
hydrophobicity, molecular weight, surface charge, and other 
parameters [65]. 
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Triclosan  
Triclosan is one of the common antimicrobial agents used in 
emulsion form against the microorganism. Triclosan mixed with 
water-based styrene-acrylate emulsion found to be very effective 
against Enterococcus faecalis. The release of triclosan is based upon 
the solvent system used. Studies have shown that its release is very 
slow when water alone used as the solvent system while its release 
speeds up in n-heptane [66]. Triclosan, when incorporated in water-
dispersible polyvinyl alcohol nanoparticles, showed greater 
antibacterial activity against Corynebacterium [67]. 
N-halamine compounds 
In N-halamine compounds there is the presence of a reactive free 
halogen, which is responsible for its antimicrobial property, as with 
the release of this reactive halogen, the microbial cells get 
deactivated. Structurally, these compounds contain one or more 
nitrogen-halogen covalent bonds that are usually formed by 
halogenation of imide, amide, or amine groups. This provides them 
stability and also facilitates the slow release of active halogen 
species into the environment. These oxidizing halogens promote the 
direct transfer of an active element of the biological target site or 
through dissociation to free halogen in aqueous media [68]. 
Polysiloxanes 
Polysiloxanes are linear polymers of silicon oxide. Their statistical 
block type copolymers containing quaternary ammonium salt 
groups as a lateral substituent found to be effective against 
Escherichia coli and Staphylococcus aureus [68]. Upon coming in 
contact with bacterial membrane they burst the membrane and 
results in the death of the microorganism.  
Peptides 
These are synthesized by the ring opening polymerization of amino 
acid monomer using various hydrophobic and hydrophilic amino 
acid. Most commonly peptide synthesized by ring opening 
polymerization of α-amino acid N-carboxy anhydride, which is a 
monomer using lysine as a hydrophilic amino acid and alanine (A), 
phenylalanine (F), and leucine (L) as hydrophobic amino acid. By 
varying the content of hydrophobic from 0-100 % five different 
kinds of co-peptides were synthesized (i.e., P(KA), P(KL), P(KF), 
P(KAL), P(KFL)). It was observed that polymer synthesized using 
phenylalanine showed better antimicrobial activity than that 
synthesized by leucine or alanine. Theses polymers have shown 
potential against Escherichia coli, Pseudomonas aeruginosa, Serratia 
marcescens, and Candida albicans [69]. 
5-Chloro-8-hydroxyquinoline 
Another important antimicrobial polymer includes the polymers of 
acrylate containing 5-chloro-8-hydroxyquinoline. For their 
hydrolytic behaviour they were studied at physiological, acidic, 
and basic pH. It was observed that in theses polymers hydrolysis 
occurs by autocatalysis and is potentiated by pH, temperature and 
content of hydrophilic polymers. Their mechanism involves the 
disruption of cell membrane and there, by disturbing the 
membrane integrity [70]. 
Quaternary phosphonium or sulfonium groups 
These are the polycationic polymers that contain quaternary 
phosphonium or sulfonium groups. They are effective against the 
microorganism as they have positively charged moieties which 
electrostatically interacts with the negatively charged bacterial 
membrane. Their hydrophobic tail integrates with hydrophobic 
membrane core, where it damages the proteins, enzymes and other 
cofactors that are required for normal metabolism and thus kills the 
bacteria. Due to the presence of phosphonium theses, polycationic 
polymers are found to be more effective than quaternary ammonium 
salt polymers. It was well documented that with the increase in the 
length of alky chain and phosphonium units the antimicrobial 
potential of the compound was enhanced. Antimicrobial potential of N-
isopropylacrylamide and methacryloyloxyethyl trialkyl phosphonium 
chlorides was increased to a greater extent with the increase in alkyl 
chain length and phosphonium [71]. 
Benzoic acid, phenol, and p-hydroxybenzoate esters 
Esters of benzoic acid, phenol and p-hydroxy benzoate are most 
commonly used as disinfectants. In a monomeric form, they are well 
documented and established antimicrobial agents. For the synthesis 
of new and more efficient antimicrobial agents, e attempts have 
been made to incorporate polymeric backbone in their structure. 
Three components have been incorporated with them viz: p-
hydroxyphenyl acrylate, allyl phydroxyphenyl acetate, and p-2-
propen oxyphenol, and it was found that p-phydroxyphenyl acrylate 
showed the maximum antimicrobial potential against both the 
bacteria and fungi[72]. This activity is attributed due to the presence 
of phenyl group, which exerts stereoelectronic effect. Compounds 
with acryl or acryloxy groups bound to the phenyl moiety exhibit 
superior antimicrobial activities [73]. Benzaldehyde also belongs to 
this class which is known for its wide range of bactericidal, 
fungicidal, and algaecidal activities. When this benzaldehyde 
attached with the polymer of methyl methacrylate, it showed 
activity against Bacillus macroides, Pseudomonas aeruginosa and 
Dunaliella tertiolecta [74]. 
Polycationic nanoparticles 
The polycationic nanoparticle is unique in its ability to kill the 
microorganisms. Unlike other organic nanoparticles, it induces 
programmed cell death in the target microorganism. Although, it is 
still debatable that whether the nanoparticles induces such signals 
or not, but if it is there it can be very helpful in case of biofilm as 
antibiotics have poor ability to penetrate inside the biofilm [21]. Yet 
there are growing evidence in this context. 
Polymeric nanosized antimicrobials 
Theses nanosized antimicrobial agents are nonvolatile and 
chemically stable. In addition to long-term antimicrobial activity, 
being polymeric in nature, they can bind to the surface of interest 
and also does not penetrate the biological membrane of skin [75]. As 
these are polycationic in nature so they have a high surface density 
of active groups which is responsible for their high efficacy against 
microbes. Quaternary ammonium compounds have been reported to 
express a broad range of antimicrobial activity against both Gram-
positive and Gram-negative bacteria. Polyamines are quaternary 
ammonium polyethyleneimines that are proved to be highly 
effective antimicrobial nanoparticles. Theses polyamines after 
incorporation into various polymeric matrixes showed a wide range 
of bacterial targets [76]. Lipid nanoparticles also showed the higher 
extent of the biocompatibility wide range of microbes as a target.  
Chitosan 
Chitosan is very well known organic compound having wide range of 
antibacterial, antiviral, and antifungal activity. Its conjugated form with 
hydroxycinnamic acid showed the enhanced activity than that of 
chitosan alone [77]. Its widespread application is credited to its 
characteristics being biocompatible, nontoxic, low immunogenic, higher 
antibacterial property and capacity to act as an absorption enhancer. 
These nanoparticles are obtained by N-deacetylation of the N-acetyl 
glucosamine polymer chitin, which is commonly found in the 
exoskeleton of insects. Some reports have shown that when it gets 
attached with metal (Zn) it reduces its activity [66]. So for better activity, 
it should be preferably bound with the antibiotics [78]. Its mechanism of 
action is not much clear, but reports have shown that it affects drug 
efflux system, respiration and respiration nodulation cell division and 
also the drug transport system. It is believed that it may be due to the 
interaction of membrane lipopolysaccharide with chitosan. As this 
interaction, results in destabilization of membrane protein due to which 
the membrane of the organism lyse and hence leads to death [79]. 
Antiviral studies on nanoparticles  
Much of the research is dedicated to the antibacterial potential of 
various nanoparticles, but the area of serious viral infection still 
needs to be explored. The disease caused by a viral infection is 
equally imperative. There are many viral infections that have 
affected throughout the world and need attention due to their 
health, social and economic impact. Targeting the virus and 
maintaining the host cell viability is a challenging task. Of so many 
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nanoparticles, metal nanoparticles have been tested for their 
antiviral potential due to their structure of core material or ligands 
shell [80]. Silver nanoparticles show a promising result against HIV-
1 at non-cytootoxic concentrations. There are a number of in vitro 
assays that have demonstrated the mechanism of antiviral activity of 
silver nanoparticles. Silver nanoparticles exert its antiviral activity 
at an early stage of viral replication. It has been shown that it acts 
like a virucidal agent or inhibits the viral entry. To act as a virucidal 
agent in both cell-free virus and cell-associated virus, it inhibits CD4-
dependent virion binding, fusion and stops its infection causing 
ability. Moreover, silver nanoparticles inhibit post-entry stages of 
the HIV-1 life cycle and thereby acting against a variety of circulating 
HIV-1 strains [80]. In addition to silver nanoparticles, gold 
nanoparticles have also exhibited antiviral properties [81]. The in 
vitro studies has shown tat gold nanoparticles that are coated with 
multiple copies of an amphiphilic sulfate-ended ligand binds itself to 
the HIV envelop glycoprotein gp120 and inhibits HIV infection of T-
cells. Theses nanoparticles actually create a high concentration zone 
for the binding of glycoprotein gp120, and as a result the virus binds 
itself to the nanoparticle rather than the biological entity at a 
nanomolar concentration. To infect, theses viruses follows the 
adsorption or the fusion pathway and when they get multivalent 
gold nanoparticles with sulfated ligand they binds themselves to 
theses nanoparticles. Frequency of binding of gp120 glycoprotein 
with virus depends upon the ligand density [82]. 
Gold nanoparticles with various anionic groups exhibited the 
activity against influenza virus also [83]. These virus binds with the 
cell surface of the host, gold nanoparticles inhibits the binding of the 
virus to the host cell surface by blocking the binding sites. This 
antiviral property of anionic gold nanoparticles is attributed to the 
charge density and functional groups present 0n the surface of the 
gold nanoparticle. As these anionic gold functional group interacts 
with the viruses by multivalent bonds and the small size of the gold 
nanoparticles facilitate their entry through the endosome vesicle, 
possibly allowing them to hinder the fusion step of infection also 
[84]. Most important aspects of gold nanoparticles is this that in 
addition to the antiviral property they have exhibited no or very low 
toxicity [85]. Gold nanoparticle, composed of gold core bonded with 
mercaptoethanesulfonate on its surface through the thiol group 
exhibited no toxicity to normal cell and also inhibited the various 
influenza strains including the most recent pandemic swine 
influenza virus H1N1 strain. This study revealed that the effect of 
gold nanoparticle is not limited to some particular influenza strain.  
Studies have also revealed the potential effect of silver nanoparticles 
coated with mercaptoethane sulfonate against Herpes simplex virus 
Type 1 [86]. Theses nanoparticles have sulfonate end groups that 
compete with viruses for the binding to cellular heparin sulfate. As 
theses nanoparticles bind with cellular heparin sulphate they block 
the entry of the virus into the cell and subsequently stop the 
infection. In addition to antiviral potential against Herpes simplex 
virus, they did not impart any cytotoxicity to host cells. Due to the 
heparin sulfate dependence for entry, these can be further used as 
the topical agent also. There are studies that have shown its 
effectiveness against HIV-1, monkeypox virus, respiratory syncytial 
virus and hepatitis [87, 89]. Thus, nanoparticles with a 
functionalized group ion their surface can be used as antiviral 
agents. 
Antifungal activity of metal nanoparticles 
There are several fungal infections that needed to be treated with 
multiple antibiotics in immune-compromised patients. Although 
there are a lesser number of studies showing fungistatic and 
fungicidal effects of nanoparticles but some of them is still explored. 
Silver nanoparticles have been explored for their fungistatic and 
fungicidal effects on the specific pathogenic yeasts causing life-
threatening fungal infections in the patients that are in intensive 
care. Antifungal property of silver nanoparticle has been tested and 
proved to be effective against pathogenic Candida sp. [90]. There are 
reports showing the potential activity of silver nanoparticles against 
Trichophyton mentagrophytes, dermatophytes and Candida species. 
Their antifungal potential is due to its effect on mycelia [91]. Silver 
nanoparticles targets the cell membrane of yeast cells, it creates 
pits/pores in its membrane and thereby disturbing its membrane 
potential. The formation of pores in the membrane subsequently 
leads it to death [92]. 
Methods of preparation of Nanoparticles 
Nanoparticles can be formulated with a variety of materials 
including proteins, polysaccharides and synthetic polymers. Three 
common methods include 
a) Dispersion of Preformed polymers 
b) Polymerization of Monomers 
c) Ionic gelation or Coacervation of hydrophilic polymers 
Of these three, dispersion of preformed polymers is most common, 
and this technique can be used in various ways 
a) Solvent evaporation method 
b) Spontaneous emulsification or solvent diffusion method 
c) Polymerization method 
d) Coacervation/Ionic gelation Method 
e) Supercritical fluid technology 
a) Solvent evaporation method  
In this method, polymer is first dissolved in organic solvent. 
Hydrophobic drug is also dissolved in the same solvent, which is 
used to dissolve the polymer. Both are then mixed in a solution 
containing a surfactant or emulsifying agent. As a result, oil in water 
emulsion is formed. After achieving the stability of this emulsion 
organic solvent is evaporated (by reducing pressure/continuous 
stirring). It is then subjected to high-speed homogenization or 
ultrasonication to achieve small, particle size [93]. 
b) Spontaneous emulsification/solvent diffusion method  
In this technique mixture of water-miscible solvent and a small 
amount of water-immiscible organic solvent is used. This results in 
the spontaneous diffusion of solvents and leads to interfacial 
turbulence between two phases. This results in the formation of 
small particles [94]. 
c) Polymerization method  
For the formation of nanoparticles, monomers are polymerized in 
aqueous solution. The drug is incorporated either by dissolving in 
polymerization medium or by adsorption onto the nanoparticles. 
Nanoparticle suspension is then subjected to ultracentrifugation to 
remove surfactants or stabilizers. After the completion of 
ultracentrifugation, particles are re-suspended in the isotonic 
surfactant free medium [95]. 
d) Coacervation/ionic gelation  
In this method, biodegradable hydrophilic polymer like chitosan, 
gelatin or sodium alginate is used. Two aqueous phases one is 
polymer chitosan and another is polyanion sodium 
tripolyphosphate) is taken and mix well. Positively charged chitosan 
interacts with negatively charged triphosphate. Due to the 
electrostatic interaction between two phases, they got bound top 
each other, forming coacervates with a size in nanometers [96-97]. 
e) Supercritical fluid technology  
This method is used to overcome the hazardous effect of organic solvent 
as it is harmful to the environment as well as to physiological systems. 
Supercritical fluids are those solvents that remain in their fluid state 
above its critical temperature regardless of pressure (Most widely used 
supercritical fluid is CO2). But this technique is more expensive and can 
be achieved by Supercritical anti-solvent or rapid expansion of critical 
system method in special equipment [98]. 
Nanoparticles for antimicrobial drug delivery 
With the passage of time and due to the limitations of conventional 
dosage or delivery system, studies have been conducted to find out 
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the alternatives. Most important aspects of drug delivery involve 
that it should possess 
a) Controlled drug delivery 
b) Targeted drug delivery 
The nanoparticle has come into sight as an effective and potential 
drug delivery system. Drugs are effective only at a particular 
concentration. As discussed earlier in the section that nanoparticles 
have such surface properties that can help in controlled and targeted 
drug release. Due to their ultra-small and controllable size, they can 
easily penetrate body cells and can function well. Nanoparticle-
mediated drug delivery offers many advantages over the 
conventional therapy that can be summarized as  
a) Enhanced therapeutic efficacy of drugs due to the controlled 
and sustained release of drug at the site of action. 
b) Better bioavailability and the right proportion of drug at the 
targeted site. 
c) The drug can be incorporated in the system without any 
chemical reaction. 
d) Multiple drugs can be delivered to the same cell for combined 
synergistic therapy. 
e) Drug release and degradation profile can be modified, simply 
by modulating the size of the nanoparticle.  
Lipid-based 
Liposomes are spherical phospholipid bilayer vesicles with a 
structure consisting of amphiphilic lipid molecules shown in fig. 2.  
They possess the efficient properties like lipid polymorphisms, lipid, 
protein and lipid drug interaction. In 1995, Doxil (Doxorubicin 
liposome) became the first liposomal drug delivery system to treat 
AIDS-associated Kaposi’s sarcoma after the approval of food and 
drug administration [98-99]. Most commonly used lipid is 
phosphatidylcholine, which is an eclectically neutral phospholipid 
containing chain of fatty acyl of varying degree of saturation and 
length. Usually, cholesterol is incorporated to maintain the 
membrane rigidity and stability. Based upon the structure 
specification they are broadly classified into multilamellar vesicles 
(and unilamellar vesicles (fig. 3). 
 
 
Fig. 2: Schematic illustration of liposome [150] 
 
 
Fig. 3: Classification of liposomes [99] 
 
Multilamellar vesicles possess multiple phospholipid layers while 
unilamellar vesicles have single phospholipid layer. While preparing 
liposome following parameters are taken into account 
a) Physicochemical characteristics of liposomal ingredients 
b) Materials to be contained within the liposome 
c) Particle size 
d) Shelf time 
e) Polydispersity 
f) Surface zeta potential 
For the formulation of the liposome sufficient amount of energy 
via sonication, homogenization, shaking/heating is supplied to 
phospholipid placed in water. Sonication method is most 
preferable [100]. The in vivo stability of liposomes can be 
enhanced by providing "stealth" material on its surface. Like 
polyethene glycol is frequently conjugated with liposome that 
creates stealth layer and prolongs its circulation lifetime in the 
bloodstream. Polymyxin B-loaded nanoparticles are found to be 
quite effective against P. aeruginosa related infections. Liposomal 
encapsulation of polymuxin B has limited the side effect of the 
drug [101]. Another success story is of Am Bisome, which is a 
liposomal formulation of amphotericin B to treat Candida spp., 
Aspergillums spp. and other fungal infections in neutropenic, 
visceral leishmaniasis and methylmalonic academia patients. In 
table 2 some of the liposomes has been summarized. 
Polymeric nanoparticles  
These can be formed as nanospheres or nanocapsules fig. 4, is 
depicting its structure. Nanospheres are spherical matrix system in 
which drug is uniformly dispersed whereas nanocapsules are 
vesicular systems in which drug is confined to a cavity surrounded 
by a polymeric membrane. 
In addition to being biodegradable and biocompatible they have 
following properties for antimicrobial drug delivery:- 
a) There are structurally stable and can be synthesized with shape 
size distribution. 
b) During their synthesis, by selecting different polymer length, 
surfactants and organic solvents their particle properties viz., size, 
Zeta potential and drug release can be precisely tuned. 
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Table 2: Various liposomes formulations and their effect as antimicrobial drug delivery system 
Liposomal formulation Drug Targeted microorganism Action Reference 
Dipalmitoylphosphatidylcholine (DPPC), 
cholesterol, and dimethylammonium 
ethane carbamoyl cholesterol (DC-chol) 
Benzylpenicillin Staphylococcus aureus A small amount of drug, 
penetrates the membrane 
in a lesser amount and 
thus disrupts cell 
membrane integrality 
102 
Hydrogenated soy phosphatidylcholine, 
cholesterol,  
distearoylphosphatidylglycerol (DSPG) 
Amikacin Gram-negative bacteria Bacteria is exposed for a 









-Increased drug uptake by 
Macrophages 
-amplified intracellular 
antimicrobial effect of 
each drug 
104 
Hydrogenated soy phosphatidylcholine, 
cholesterol, 
distearoylphosphatidylglycerol (DSPG) 
Amphotericin B Aspergillus fumigatus -Drug delivery is targeted 
at the site of infection 
105 
Soybean phosphatidylcholine (PC) and 
cholesterol 
Ampillicin Micrococcus Luteus and 
Salmonella typhimurium 
-augmented activity and 
stability of the drug 
106 
1,2-dipalmitoyl-sn-glycero-3- 
Phosphocholine (DPPC) and cholesterol 
Polymyxin B Pseudomonas aeruginosa -decrease bacteria count 
in lung 
-Enhanced bioavailability  
-condensed lung injury 
caused by bacteria 
107 
 
c) Their surface contains functional groups that can be easily 
modified either with drug moieties or targeting ligands as per the 
requirement. Like, polymeric nanoparticles can be bound with lectin 
which is a carbohydrate that easily binds to most of the bacterial cell 
wall. Umamaheshwari et al., 2003 studied lectin conjugated gliadin 
nanoparticle against the infection caused by Helicobacter pylori and 
found it to be quite helpful in overcoming the infection [108]. 
Initially, the use of polymeric nanoparticle did not attain the success 
due to the rapid clearance by the reticuloendothelial system after 
intravenous administration. But later the problem was resolved by 
using long-circulating stealth polymeric nanoparticle [109]. 
There are mainly two types of polymeric nanoparticles.  
a) The one formed by spontaneous self-assembly of di-block 
copolymers consisting of hydrophobic and hydrophilic segments. 
The hydrophobic segment comprises the polymeric core that 
contains the drug while hydrophilic segment protects the core from 
opsonisation and degradation. Now, the rate at which drug release is 
required can be controlled by varying the length of hydrophobic 
chain, forming the core of polymer. Commonly used hydrophobic 
polymer core includes poly (Lactide-co-glycolide), poly (glycolic 
acid) PGA, Poly (cyano-acrylate) PCA, whereas commonly used 
hydrophilic segment is polyethene glycol. These are formed by the 
solvent evaporation method. 
b) Like an amphotericin-B loaded poly (ε-caprolactone) 
nanospheres coated with non-ionic surfactant poloxamer 188 
has shown great therapeutic efficacy against Leismania donovani 
as compared to free drug counterparts [110]. Some of the 
polymeric nanoparticles with their efficacy have been 
recapitulated in table 3. 
 
 
Fig. 4: Schematic illustration of polymeric nanoparticles [151]
 
Table 3: Various polymeric nanoparticle formulations and their effect as antimicrobial drug delivery system 
















HIV -Protection of oligonucleotides from 
Degradation 
112 










Ciprofloxacin Staphylococcus aureus 
and Bacillus anthracis 
-Enhanced bioavailability 





Halofantrine Plasmodium berghe -Extended circulation half-life 115 
Poly (D,L-lactide) (PLA) 
Nanospheres 
Arjunglucoside Leishmania donovani -Abridged toxicity 116 
Poloxamer 188 coated 
poly(epsiloncaprolactone) 
(PCL) nanosphere 
Amphotericin B. Candida albicans -Lower in vivo toxicity due to 
reduced accumulation in kidney and 
liver 
117  
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Dendrimers 
Dendrimers are highly branched, regularly ordered globular 
macromolecular with 3-D structures, shown in fig. 5 which provide a 
high degree of surface functionality and versatility [118]. They 
mainly consist of 3 components: An initiator core, an interior layer 
composed of repetitive units and a terminal functionally layer 
attached to the outermost interior layer for the formulation of 
dendrimer nanoparticle dendrimer nanoparticles there are two 
approaches, one is divergent and another one is convergent. In the 
divergent approach, synthesis starts from the core and proceeds 
outwards by repetition of coupling and activation steps. Whereas, in 
the convergent approach, synthesis starts from the outer side 
(peripheral) and proceeds towards the core [119]. Dendrimers 
posses many exceptional properties that make them dexterous 
nanoparticles. 
a) They have highly branched 3-D structure which gives them an 
adequate amount of surface area to size ratio and allows great 
relatively with microorganisms in vivo.  
b) There is an accessibility of many controlled functional surface 
groups, poly disparity and their ability to imitate cell membrane 
adds to their potency as drug carriers. 
c) Both hydrophobic and hydrophilic drugs can be uploaded, the 
hydrophobic drug can be uploaded inside the cavity and hydrophilic 
drugs can be attached to multivalent surfaces of dendrimers through 
covalent conjugation or electrostatic interaction [120].  
d) Dendrimers with specific and high binding affinity for various 
viral and bacterial receptors can be synthesized [121]. For their 
prolonged stay in the circulatory system, they can be functionalized 
with Polyethylene glycol. 
Moreover, by taking antimicrobial drugs as their building blocks 
they themselves become efficient antimicrobials. Dendrimers have 
greater antimicrobial efficacy than small drug molecules because of 
the high density of antimicrobials present on their surfaces. The 
polycationic structures facilitate the electrostatic adsorption to 
negatively charged bacteria. This adsorption increases membrane 
permeability and makes a passage for more dendrimers for entering 
in the bacteria leading to the leakage and eventually complete 
disintegration of the bacterial membrane [122]. 
A polyamidoamine dendrimer is the first dendrimer that becomes very 
popular but, become of toxicity due to terminal amine; its clinical use 
was limited. However, by masking these terminal amines, this limitation 
was resolved. Table 4 is showing commonly used dendrimers. 
] 
 
Fig. 5: Schematic illustration of dendrimers [118]
 
Table 4: Various dendrimers formulation and their effect as antimicrobial drug delivery system 





Various bacteria -Enhanced water solubility 123 
Sulfamethoxazole Streptococcus,  
staphylococcus aureus, 
Haemophilus influenza 
-Steady drug release 
-superior antibacterial activity 
124 
Silver salts (Staphylococcus aureus, 
Pseudomonas aeruginosa, and 
Escherichia coli) 
-Elevated payload 
-extended circulation half-life 
125 
Pegylated lysine based 
copolymeric dendrimer 
Artemether Plasmodium falciparum -Augmented drug stability 
-augmented solubility 
-extended drug circulation half-life 
126 
 
Solid lipid nanoparticles  
Solid lipid nanoparticles are colloidal drug carries shown in fig. 6 
and attracted much attention since 1990's. Their size ranges from 
52-100 nm and consist of physiologically biocompatible lipids, which 
remain solid at body and room temperature and disperse in aqueous 
solution. The lipids used to prepare SLNs include fatty acids (palmitic 
acid, decanoic acid), triglycerides (trilaurin, trimyristin), steroids 
(cholesterol) partial glycerides (glycerol monostearate) and waxes. 
Emulsifiers like soyabean lecithin, poloxamer 188, sodium cholate etc., 
are used to stabilize lipid dispersion.  
To prepare Solid lipid nanoparticles (SLN’s) high-pressure homo-
genization emulsifier solvent diffusion and multiple emulsion solvent 
injections are commonly used. 
These SLN's has many advantages as a drug carrier system that is 
summarized as follows. 
a) Drug release can be controlled and targeted for immediate 
release or sustained release. 
b) They are made up of physiological, biocompatible and tolerable 
lipids and thus non-toxic to the human body. 
c) These formulations protect sensitive drugs from any 
photochemical or oxidative degradation as the drug is immobilized 
by solid lipids and drug leakage is reduced as compare to liposomes. 
d) A slight modification in the SLN’s formulation helps in the 
encapsulation of both lipophilic and hydrophilic drugs. 
e) They possess property, which is unique in itself, as an 
application on skin, they readily forms a thin film to reduce water 
evaporation and retain skin moisture. This promotes their 
penetration into the skin. Like SLN’s encapsulated antimicrobial 
agent (retinol and retinyl palmitate) have shown better drug 
penetration rate than that of their free drug [127]. Moreover, they 
are stable in water and chemical cream so can be incorporated in 
cosmetics and skin care products. 
In addition to the topical application, they can be taken orally in variable 
conditions. Tobramycin is a drug used to treat Pseudomonas aeruginosa 
infections in fibrosis patient.[128] But, the rate of absorption of 
tobramycin is very low by the intestinal cells because P-glycoproteins on 
the brush border of the small intestine actively export the drugs from the 
cells. While tobramycin-loaded SLN’s significantly suppresses the P-
glycoprotein efflux pump and helps in better transport of tobramycin 
inside the cells. Table 5 shows some of the beneficial SLN’s.  
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Besides the above-mentioned nanoparticles, there are some other 
organo metallic-based systems that are quite helpful as drug 
delivery carriers.  
Many new drugs like paclitaxel have been found to have low 
aqueous solubility but high therapeutic efficiency. Nanoparticles are 
quite helpful in such conditions. 
 
Fig. 6: Schematic illustration of solid lipid nanoparticle [127] 
 
Table 5: Various solid lipid nanoparticles formulations and their effect as antimicrobial drug delivery system 
SLN’s formulation Drug Targeted microorganism Action Reference 
Glyceryl tripalmitate and 
tyloxapol 
Clotrimazole Fungi -Extended drug release 
-high physical stability 
High encapsulation efficiency 
129 
Stearic acid, soya 
phosphatidylcholine, and sodium 
taurocholate 
Obramycin Pseudomonas aeruginosa -Increased drug availability 130 




-Advanced residence time 




Glycerol palmitostearate Econazole nitrate Fungi -High encapsulation efficiency 
-controlled drug release 
profile  
-enhanced drug penetration 
through stratum corneum 
132 
Glyceryl behenate and sodium 
deoxycholate 
Ketoconazol Fungi -Augmented physical stability 133 
Stearic acid, soya 








-Extended drug release 134 
 
Nanoparticles and biocompatibility 
Nanoparticles are in use for various biomedical applications viz., for 
the treatment of wounded infections, in drug delivery, as biosensors, 
as an antimicrobial agent. During their usage, they come in direct 
contact with various tissues and cells depending upon their mode of 
delivery, such as through oral ingestion, topical, inhaled or 
intravenous administration. The effect of various nanoparticles on a 
variety of tissues and cells is not very well understood, but their 
effect can be studied in vivo and in vitro. For the in vitro study, 
usually a cell culture method is used, where its carcinogenic 
potential, genotoxicity and cell proliferation pattern is studied. 
There are studies showing the cytotoxic [135], genotoxic [136] and 
carcinogenic [137] impact of metal-based nanoparticles, they have 
also shown the apoptosis-inducing potential [138] of metal-based 
nanoparticles. The activity of the nanoparticles is dependent upon 
their characteristics like electrical charges, their size, exposure 
concentration, shape, the surface structure of nanoparticles and on 
the individual characteristic of the metal and nonmetal used. 
Titatnium foils are covered with vertically aligned titanium dioxide 
nanoporous surface that facilitates its use. This vertical alignment 
enhances proliferation, mineralization of osteoblasts, vasodilation of 
endothelial cells and also the mobility [138]. It is also observed that 
the growth rate of osteoblasts increases three to four folds after 
exposure to titanium dioxide nanotubes [140]. The toxicity of 
nanoparticles also depends upon the size and charge of the 
nanomaterial used. Smaller size of negatively charged silicon dioxide 
has a strong blow on cell viability and genotoxicity, while their 
larger particles (100 nm) do not affect the cellular activity. Silver 
nanoparticles and gold nanoparticles are found to be more friendly 
and the biocompatible to the human cells [141]. Sodium oleate-
coated nanoparticles have also shown a considerable amount of 
biocompatibility with human cells [142]. It is necessary that after 
the in vitro studies the nanoparticles should be assessed in animal 
models. Zinc oxide nanowires is tested in Hela and L929 culture 
cells, where it has responded well to Hela at all the concentration 
while it showed good result only at a lower concentration in L929 
culture cells as it reduced the cell viability at higher concentrations 
[143]. The cytotoxic behaviour of nanoparticles varies from the 
higher animals to lower and also to the cell cultures. The 
biocompatibility of various nanoparticles can be modulated by slight 
variations in their surface structure. It has been observed that, 
nanoparticles affects directly to the major organs like heart, lungs or 
brain of the host. Studies have shown that Gold nanoparticles, when 
inhaled in rats at higher doses and at regular intervals, get 
accumulated in the lungs, which results in inflammation and 
increase in a number of macrophages [144]. The size-dependent (10, 
50, 100, and 250 nm) intravenous administration studies in rats has 
shown the accumulation of 10 nm size in various organs including 
brain, kidneys, heart, testis and thymus. Further eye irritation, oral 
toxicity and other factors were studied in mice and guinea pig, and it 
was concluded that gold nanoparticles should be administered for a 
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shorter period of time [145]. The exact mechanism of the toxicity is 
still not clear, but it is mainly attributed to the generation of reactive 
oxygen species. On one hand, reactive oxygen species are essential 
but are fatal to eukaryotic cells also. It is a well-known fact that 
reactive oxygen species at lower concentration is required for 
various pathways, but when they exceed the limit they lead to 
oxidative stress, resulting in an alteration in DNA, proteins and 
oxidation of lipids and thus the death of the cells. Reactive oxygen 
species generated by titanium dioxide nanoparticles resulted in an 
inflammatory response in rats, mice and hamsters [146]. The effect 
of oxidative stress is not confined to one particular organ, but it 
affects the various body system including central nervous system 
(CNS), respiratory system and even the cardiac conduction [147]. 
Likewise, there are many organic nanoparticles that have not shown 
toxic effects. Polycationic nanoparticles quaternary ammonium 
polyethyleneimines did not alter the biocompatibility as tested by 
cell viability and secretion of TNF-α by the monocytes [148]. 
Polyethyl glycol coated Nanostructured lipid carriers found to have 
valuable perspective, safe and increased residence time to delivery 
of indomethacin to the ocular surface [149]. Although nanoparticles 
have shown promising results as an antimicrobial agent, but the 
shortcoming like oxidative stress-mediated DNA damage, protein 
damage etc., cannot be ruled out. Thus, their dose, exposure time 
and other factors need to be taken care of.  
CONCLUSION 
Since ages, many conventional antimicrobial drugs are in use. But, 
with the passage of time, microbes have developed resistance against 
these antibiotics or antimicrobials. As a result, it has become a serious 
problem to treat these infectious microorganisms, resulting in life-
threatening adverse of diseases. Many new chemically modified drugs 
can be used at higher dosage leading to several side effects or even 
instigating microorganisms to develop a resistant mechanism for them 
also. Nanoparticles are offering a new era for new, efficient 
antimicrobial agents, offering effective control over the microorganism 
at lower dosage only. Their ultra-small size and biocompatible 
properties make them new lead as an antimicrobial agent. 
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